A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Clinical trial NCT02030860 · COMPLETED

Trial details

NCT number: NCT02030860
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas

Start date: 2014-01-01
Primary completion: 2015-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.